WEX to Present at BioContact 2009 Conference

VANCOUVER, BRITISH COLUMBIA, Oct 05 (MARKET WIRE) --
WEX Pharmaceuticals Inc. ("WEX" or the "Company") (TSX: WXI) announced
today that Dr. Bin Huang, President and Chief Executive Officer, will
present an overview of WEX Pharmaceuticals Inc. at BioContact Quebec
2009, which will take place this week in Quebec City. Dr. Huang will be
presenting on Wednesday, October 7 at 3:30pm at the Chateau Frontenac,
Salle Frontenac room.

About WEX Pharmaceuticals Inc.

WEX Pharmaceuticals Inc. is dedicated to the discovery, development,
manufacture and commercialization of innovative drug products to treat
pain. The Company's principal business strategy is to derive drugs from
naturally occurring toxins and develop proprietary products for the
global market.

Forward Looking Statements and Information

Certain statements herein may contain forward-looking statements and
forward-looking information within the meaning of applicable securities
laws. Forward-looking statements or information appear in a number of
places and can be identified by the use of words such as "plans",
"expects" or "does not expect", "is expected", "budget", "scheduled",
"estimates", "forecasts", "intends", "anticipates" or "does not
anticipate" or "believes" or variations of such words and phrases or
statements that certain actions, events or results "may", "could",
"would", "might" or "will" be taken, occur or be achieved.
Forward-looking statements and information are subject to such risks,
uncertainties and other factors which may cause our actual results,
performance or achievements, or industry results, to be materially
different from any future results, performance or achievements expressed
or implied by such forward-looking statements or information. See our
annual information form and our quarterly and annual management's
discussion and analysis for additional information on risks and
uncertainties relating to the forward-looking statement and information.
There can be no assurance that forward-looking statements or information
referenced herein will prove to be accurate, as actual results and future
events could differ materially from those anticipated in such statements
or information. Also, many of the factors are beyond the control of the
Company. Accordingly, readers should not place undue reliance on
forward-looking statements or information. All forward-looking statements
and information made herein, are qualified by this cautionary statement.

Contacts:
WEX Pharmaceuticals Inc.
Dr. Bin Huang
President & CEO
(604) 683-8880 or Toll Free: 1-800-722-7549
(604) 683-8868 (FAX)
wex@wexpharma.com
www.wexpharma.com

Copyright 2009, Market Wire, All rights reserved.

-0-